Rapid Dose Therapeutics Corp. (CSE: DOSE)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 24, 2024	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020
Market Capitalization	19	21	9	26	17	27
Market Cap Growth	73.12%	121.17%	-64.76%	56.16%	-36.29%	-57.36%
Enterprise Value	21	23	11	28	18	28
Last Close Price	0.15	0.17	0.09	0.26	0.21	0.34
PE Ratio	-	-4.27	-2.44	-3.01	-9.05	-3.30
PS Ratio	13.94	20.20	12.98	15.10	22.43	261.96
PB Ratio	-8.13	-6.53	-3.49	105.16	-15.55	-179.91
P/FCF Ratio	-9.66	-8.98	-10.79	-8.70	-10.38	-6.25
P/OCF Ratio	-9.66	-8.98	-10.79	-8.82	-10.43	-8.77
EV/Sales Ratio	17.95	23.00	15.75	15.81	24.39	273.86
EV/EBITDA Ratio	-9.01	-8.55	-3.53	-7.24	-14.76	-3.80
EV/EBIT Ratio	-8.39	-7.63	-3.19	-6.44	-11.27	-3.70
EV/FCF Ratio	-10.68	-10.23	-13.10	-9.11	-11.28	-6.53
Debt / Equity Ratio	-0.78	-0.78	-0.80	5.69	-2.01	-9.15
Debt / FCF Ratio	-0.92	-1.07	-2.46	-0.47	-1.34	-0.32
Asset Turnover	0.61	0.49	0.27	0.51	0.19	0.02
Inventory Turnover	2.55	2.79	1.66	1.26	0.43	0.37
Quick Ratio	0.12	0.13	0.04	0.09	0.08	0.03
Current Ratio	0.24	0.23	0.09	0.25	0.19	0.12
Return on Equity (ROE)	-	-	-	-	-	-432.88%
Return on Assets (ROA)	-113.93%	-93.10%	-83.34%	-77.93%	-25.16%	-93.14%
Return on Capital (ROIC)	-	-	-389.55%	-193.25%	-88.74%	-186.45%
Earnings Yield	-30.41%	-20.89%	-40.87%	-32.08%	-10.66%	-29.96%
FCF Yield	-10.35%	-11.13%	-9.27%	-11.49%	-9.64%	-16.01%
Buyback Yield / Dilution	-5.85%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%
Total Shareholder Return	-5.85%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%

Source: S&P Capital IQ. Standard template. Financial Sources.